Ngā hua rapu - Colm O’Morain
- E whakaatu ana i te 1 - 20 hua o te 59
- Haere ki te Whārangi Whai Ake
-
1
-
2
Therapeutic benefits of budesonide in gastroenterology mā Sarah O’Donnell, Colm O’Morain
I whakaputaina 2010Artigo -
3
Current therapeutic options for gastric antral vascular ectasia mā Shaji Sebastian, Colm O’Morain, Martin Buckley
I whakaputaina 2003Revisão -
4
-
5
-
6
-
7
-
8
Treatment of <i>Helicobacter pylori</i> Infection mā Anthony O’Connor, Javier P. Gisbert, Colm O’Morain
I whakaputaina 2009Revisão -
9
Elemental diets in treatment of acute Crohn's disease. mā Colm O’Morain, Anthony W. Segal, A J Levi
I whakaputaina 1980Artigo -
10
-
11
-
12
-
13
-
14
-
15
-
16
Treatment of <i>Helicobacter pylori</i> Infection 2011 mā Anthony O’Connor, Javier P. Gisbert, Deirdre McNamara, Colm O’Morain
I whakaputaina 2011Revisão -
17
-
18
Treatment of <i><scp>H</scp>elicobacter pylori</i> infection in 2018 mā Neil O’Moráin, Maria Pina Dore, Anthony O’Connor, Javier P. Gisbert, Colm O’Morain
I whakaputaina 2018Revisão -
19
-
20
Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting. mā Han Xia, Henry J. Windle, D. G. Marshall, Cyril J. Smyth, C. T. Keane, Colm O’Morain
I whakaputaina 1995Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Gastroenterology
Biology
Helicobacter pylori
Disease
Microbiology
Antibiotics
Intensive care medicine
Inflammatory bowel disease
Crohn's disease
Clarithromycin
Genetics
Metronidazole
Gastritis
Amoxicillin
Gene
Helicobacter pylori infection
Ulcerative colitis
Cancer
Environmental health
Family medicine
Immunology
Pathology
Stomach
Antibiotic resistance
Cohort
Genotype
Nursing
Population